Concurrently, Moody’s affirmed its “Aa2” rating on IU Health’s outstanding bonds.
The assignment and affirmation are a result of several factors, including the health system’s strong operating performance, healthy regional market position, sustained margins and liquidity growth. Moody’s also acknowledged IU Health’s increasingly competitive market, high reliance on government payers and upcoming period of high capital spending.
The outlook is stable, reflecting Moody’s expectation that IU Health will maintain solid margins and healthy liquidity metrics to support the period of high capital spending.
More articles on healthcare finance:
Mission Hospital to name cancer institute after donors of record-setting gift
7 latest hospital credit downgrades
10 hospitals seeking RCM talent
